Literature DB >> 2570823

New CD4(+) cell line susceptible to infection by HIV-1.

M Tremblay1, A K Sullivan, R Rooke, R Geleziunas, C Tsoukas, G Shematek, N Gilmore, M A Wainberg.   

Abstract

Infection of a newly described human T lymphoid cell line, CEM-CL10, with three different variants of HIV-1 resulted in cytopathic effects followed by cell lysis. Following primary lytic infection, proviral DNA could not be detected by Southern blot analysis in the outgrowth of the surviving CEM-CL 10 cells 60 days after initial exposure to HIV-1. These surviving cells could be further grown as a separate line, derived from CEM-CL10, and were found to be resistant to subsequent infection by HIV-1. A marked decrease in CD4 antigen expression was observed in these latter cells but not of the CD3 and transferrin receptor antigens. This decline in cell surface CD4 expression was correlated with both an absence of specific CD4 mRNA and with changes in structure of the CD4 gene. Both the HIV-1-sensitive CEM-CL10 cell line and its CD4(-), HIV-1-resistant derivative line, will be made available to interested investigators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570823     DOI: 10.1002/jmv.1890280408

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.

Authors:  Q Gao; Z X Gu; M A Parniak; X G Li; M A Wainberg
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.

Authors:  Dimiter G Demirov; Jan M Orenstein; Eric O Freed
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.

Authors:  Charline Giroud; Mariana Marin; Jason Hammonds; Paul Spearman; Gregory B Melikyan
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

4.  In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy.

Authors:  L M Mansky
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Authors:  Marek Widera; Steffen Erkelenz; Frank Hillebrand; Aikaterini Krikoni; Darius Widera; Wolfgang Kaisers; René Deenen; Michael Gombert; Rafael Dellen; Tanya Pfeiffer; Barbara Kaltschmidt; Carsten Münk; Valerie Bosch; Karl Köhrer; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

6.  A Quantitative Live-Cell Superresolution Imaging Framework for Measuring the Mobility of Single Molecules at Sites of Virus Assembly.

Authors:  Nicholas S Groves; Merissa M Bruns; Schuyler B van Engelenburg
Journal:  Pathogens       Date:  2020-11-21

7.  Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14+ Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines.

Authors:  Huxley K Hoffman; Rebekah S Aguilar; Austin R Clark; Nicholas S Groves; Nairi Pezeshkian; Merissa M Bruns; Schuyler B van Engelenburg
Journal:  J Virol       Date:  2022-06-30       Impact factor: 6.549

8.  A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.

Authors:  Marek Widera; Frank Hillebrand; Steffen Erkelenz; Ananda Ayyappan Jaguva Vasudevan; Carsten Münk; Heiner Schaal
Journal:  Retrovirology       Date:  2014-08-29       Impact factor: 4.602

9.  Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation.

Authors:  Carmen A Buttler; Nairi Pezeshkian; Melissa V Fernandez; Jesse Aaron; Sofya Norman; Eric O Freed; Schuyler B van Engelenburg
Journal:  Nat Commun       Date:  2018-05-10       Impact factor: 14.919

10.  A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread.

Authors:  Xenia Snetkov; Tafhima Haider; Dejan Mesner; Nicholas Groves; Schuyler B van Engelenburg; Clare Jolly
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.